127 related articles for article (PubMed ID: 36394865)
1. Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic.
Oakes AH; Boyce K; Patton C; Jain S
JAMA Oncol; 2023 Jan; 9(1):145-146. PubMed ID: 36394865
[TBL] [Abstract][Full Text] [Related]
2. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
4. Effects of cancer screening restart strategies after COVID-19 disruption.
Kregting LM; Kaljouw S; de Jonge L; Jansen EEL; Peterse EFP; Heijnsdijk EAM; van Ravesteyn NT; Lansdorp-Vogelaar I; de Kok IMCM
Br J Cancer; 2021 Apr; 124(9):1516-1523. PubMed ID: 33723386
[TBL] [Abstract][Full Text] [Related]
5. Effect of the COVID-19 pandemic on oncology screenings: it is time to change course.
Scioscia M; Noventa M; Palomba S; Laganà AS
BJOG; 2021 Dec; 128(13):2213-2214. PubMed ID: 34402585
[No Abstract] [Full Text] [Related]
6. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis.
Teglia F; Angelini M; Astolfi L; Casolari G; Boffetta P
JAMA Oncol; 2022 Sep; 8(9):1287-1293. PubMed ID: 35797056
[TBL] [Abstract][Full Text] [Related]
7. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
[TBL] [Abstract][Full Text] [Related]
8. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
9. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
10. Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
Sormani J; Datchoua AM; Petignat P; Kenfack B; Schmidt NC
Int J Gynecol Cancer; 2021 Sep; 31(9):1297-1298. PubMed ID: 33712454
[No Abstract] [Full Text] [Related]
11. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
12. Qualitative evaluation of a codesigned faith-based intervention for Muslim women in Scotland to encourage uptake of breast, colorectal and cervical cancer screening.
Christie-de Jong F; Kotzur M; Amiri R; Ling J; Mooney JD; Robb KA
BMJ Open; 2022 May; 12(5):e058739. PubMed ID: 35568495
[TBL] [Abstract][Full Text] [Related]
13. Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
Smith DL; Perkins RB
Prev Med; 2022 Jun; 159():107070. PubMed ID: 35461955
[TBL] [Abstract][Full Text] [Related]
14. Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
Castanon A; Rebolj M; Burger EA; de Kok IMCM; Smith MA; Hanley SJB; Carozzi FM; Peacock S; O'Mahony JF
Lancet Public Health; 2021 Jul; 6(7):e522-e527. PubMed ID: 33939965
[TBL] [Abstract][Full Text] [Related]
15. Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
Trinh TTK; Lee YY; Suh M; Jun JK; Choi KS
Epidemiol Health; 2022; 44():e2022051. PubMed ID: 35638224
[TBL] [Abstract][Full Text] [Related]
16. The First Year of the COVID-19 Pandemic: Changes in Preventive Services in Community Health Centers.
Star J; Han X; Makaroff LA; Minihan AK; Jemal A; Bandi P
Am J Prev Med; 2023 Feb; 64(2):184-193. PubMed ID: 36273931
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
Elife; 2023 Mar; 12():. PubMed ID: 36943035
[TBL] [Abstract][Full Text] [Related]
18. How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).
Dema E; Sonnenberg P; Gibbs J; Conolly A; Willis M; Riddell J; Bosó Pérez R; Copas AJ; Tanton C; Bonell C; Oeser C; Clifton S; Unemo M; Mercer CH; Mitchell KR; Field N
Sex Transm Infect; 2023 Jun; 99(4):261-267. PubMed ID: 35981863
[TBL] [Abstract][Full Text] [Related]
19. Changes in cancer screening process in primary care during the covid-19 pandemic.
Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
[TBL] [Abstract][Full Text] [Related]
20. Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.
Dockter AG; Angelos GC
Surg Technol Int; 2020 May; 36():143-147. PubMed ID: 32347964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
